ABEO Company Profile and Key Details

Q: Who are the executives of ABEO?

Mr. Joseph Walter VazzanoChief Financial OfficerMr. Gregory GinVice President of Investor Relations & Corporation CommunicationsMr. Jon VossVice President & Head of QualityMr. Dmitriy Grachev M.D., Ph.D.Chief Medical OfficerScott SantiamoDirector of Corporation CommunicationsMr. Joseph Walter Vazzano CPAChief Financial OfficerDr. Vishwas Seshadri M.B.A., Ph.D.Pres, Chief Executive Officer & DirectorMr. Joseph Walter Vazzano C.P.A.Chief Financial OfficerDr. Brendan M. O'Malley J.D., Ph.D.Senior Vice President & Gen. CounselMr. Brian Kevany Ph.D.Vice President, Chief Technology Officer & Head of ResearchMs. Alison HardgroveVice President of HR

NASDAQ : ABEO

Abeona Therapeutics

$5.95

0.52+9.58%

At Close 4:00 PM

65.34

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Abeona Therapeutics Inc. (ABEO) stock surged +9.58%, trading at $5.95 on NASDAQ, up from the previous close of $5.43. The stock opened at $5.42, fluctuating between $5.42 and $6.02 in the recent session.

Stock Snapshot

5.43

Prev. Close

339.44M

Market Cap

5.42

Day Low

5.89

P/E Ratio

1.01

EPS (TTM)

-1.46

Cash Flow per Share

5.42

Open

57.05M

Number of Shares

6.02

Day High

88.94%

Free Float in %

0.58

Book Value

1.82M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 04, 2026	5.42	6.03	5.42	5.95	1.84M
Apr 30, 2026	5.35	5.51	5.35	5.46	910.2K
Apr 29, 2026	5.33	5.47	5.22	5.34	791.12K
Apr 28, 2026	5.32	5.40	5.32	5.36	391.27K
Apr 27, 2026	5.38	5.48	5.30	5.34	597.63K
Apr 23, 2026	5.66	5.74	5.43	5.52	678.81K
Apr 22, 2026	5.42	5.67	5.40	5.63	1.05M
Apr 21, 2026	5.50	5.60	5.37	5.38	727.01K
Apr 20, 2026	5.48	5.55	5.39	5.48	697.74K
Apr 17, 2026	5.50	5.55	5.45	5.50	916.16K
Apr 16, 2026	5.40	5.43	5.29	5.38	459.34K
Apr 14, 2026	5.07	5.21	5.04	5.19	1.15M
Apr 13, 2026	4.91	5.09	4.88	5.06	790.2K
Apr 10, 2026	5.10	5.22	4.81	4.91	3.28M
Apr 09, 2026	4.82	5.25	4.82	5.12	1.97M
Apr 08, 2026	4.96	4.98	4.83	4.87	623.54K
Apr 07, 2026	4.76	4.86	4.61	4.81	992.43K
Apr 06, 2026	4.87	4.95	4.72	4.76	992.61K
Apr 02, 2026	4.50	4.84	4.50	4.82	765.86K
Apr 01, 2026	4.54	4.63	4.50	4.58	846.81K

Contact Details

Cleveland, NY 10019

United States

https://www.abeonatherapeutics.com 646 813 4701

About Company

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Abeona Therapeutics Inc. (ABEO) stock price?

Abeona Therapeutics Inc. (NASDAQ: ABEO) stock price is $5.95 in the last trading session. During the trading session, ABEO stock reached the peak price of $6.02 while $5.42 was the lowest point it dropped to. The percentage change in ABEO stock occurred in the recent session was 9.58% while the dollar amount for the price change in ABEO stock was $0.52.

ABEO's industry and sector of operation?

The NASDAQ listed ABEO is part of Biotechnology industry that operates in the broader Healthcare sector. Abeona Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABEO?

Mr. Joseph Walter Vazzano
Chief Financial Officer
Mr. Gregory Gin
Vice President of Investor Relations & Corporation Communications
Mr. Jon Voss
Vice President & Head of Quality
Mr. Dmitriy Grachev M.D., Ph.D.
Chief Medical Officer
Scott Santiamo
Director of Corporation Communications
Mr. Joseph Walter Vazzano CPA
Chief Financial Officer
Dr. Vishwas Seshadri M.B.A., Ph.D.
Pres, Chief Executive Officer & Director
Mr. Joseph Walter Vazzano C.P.A.
Chief Financial Officer
Dr. Brendan M. O'Malley J.D., Ph.D.
Senior Vice President & Gen. Counsel
Mr. Brian Kevany Ph.D.
Vice President, Chief Technology Officer & Head of Research
Ms. Alison Hardgrove
Vice President of HR

How ABEO did perform over past 52-week?

ABEO's closing price is 48.75% higher than its 52-week low of $4.00 where as its distance from 52-week high of $7.54 is -21.09%.

How many employees does ABEO have?

Number of ABEO employees currently stands at 136.

Link for ABEO official website?

Official Website of ABEO is: https://www.abeonatherapeutics.com

How do I contact ABEO?

ABEO could be contacted at phone 646 813 4701 and can also be accessed through its website. ABEO operates from 1330 Avenue of the Americas, Cleveland, NY 10019, United States.

How many shares of ABEO are traded daily?

ABEO stock volume for the day was 1.82M shares. The average number of ABEO shares traded daily for last 3 months was 1.17M.

What is the market cap of ABEO currently?

The market value of ABEO currently stands at $339.44M with its latest stock price at $5.95 and 57.05M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	136
Beta	1.21
Sales or Revenue	$3.50M
5Y Sales Change%	-0.896%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	136
Beta	1.21
Sales or Revenue	$3.50M
5Y Sales Change%	-0.896%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ABEO Company Profile and Key Details

Abeona Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Key Takeaways

Price Forecast & Outlook

Valuation Metrics